WallStSmart

High Tide Inc (HITI)vsScienture Holdings, Inc. (SCNX)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

High Tide Inc generates 87621% more annual revenue ($720.47M vs $821,320). SCNX leads profitability with a 0.0% profit margin vs -4.6%. HITI earns a higher WallStSmart Score of 43/100 (D).

HITI

Hold

43

out of 100

Grade: D

Growth: 9.3Profit: 4.0Value: 5.0Quality: 3.5
Piotroski: 2/9Altman Z: 0.68

SCNX

Hold

35

out of 100

Grade: F

Growth: 5.3Profit: 2.5Value: 5.0Quality: 7.0
Piotroski: 4/9Altman Z: 0.19

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HITI2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
32.8%10/10

Revenue surging 32.8% year-over-year

EPS GrowthGrowth
1532.0%10/10

Earnings expanding 1532.0% YoY

SCNX3 strengths · Avg: 9.7/10
Price/BookValuation
0.1x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
449.1%10/10

Revenue surging 449.1% year-over-year

Debt/EquityHealth
0.179/10

Conservative balance sheet, low leverage

Areas to Watch

HITI4 concerns · Avg: 2.8/10
Market CapQuality
$236.67M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.173/10

Elevated debt levels

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-52.8%2/10

ROE of -52.8% — below average capital efficiency

SCNX4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$4.81M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-0.1%2/10

ROE of -0.1% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : HITI

The strongest argument for HITI centers on Revenue Growth, EPS Growth. Revenue growth of 32.8% demonstrates continued momentum.

Bull Case : SCNX

The strongest argument for SCNX centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 449.1% demonstrates continued momentum.

Bear Case : HITI

The primary concerns for HITI are Market Cap, Debt/Equity, Piotroski F-Score.

Bear Case : SCNX

The primary concerns for SCNX are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

SCNX carries more volatility with a beta of 4.08 — expect wider price swings.

SCNX is growing revenue faster at 449.1% — sustainability is the question.

HITI generates stronger free cash flow (9M), providing more financial flexibility.

Monitor PHARMACEUTICAL RETAILERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HITI scores higher overall (43/100 vs 35/100) and 32.8% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

High Tide Inc

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

High Tide Inc. is a vertically integrated company in the cannabis market in Canada, the United States and internationally. The company is headquartered in Calgary, Canada.

Visit Website →

Scienture Holdings, Inc.

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

Scienture Holdings, Inc. (SCNX) is a pioneering biotechnology firm focused on transforming the treatment landscape for neurological disorders through its advanced drug development pipeline and a seasoned research team. The company is dedicated to addressing significant unmet medical needs, highlighting its potential to enhance patient outcomes while skillfully navigating regulatory complexities. With a strong emphasis on scientific integrity and strategic collaborations, Scienture is well-positioned to leverage growth opportunities in the burgeoning global healthcare market, particularly as the demand for effective neurological therapies continues to rise.

Want to dig deeper into these stocks?